The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

The synergistic relationship between psychiatric medications and psychotherapy is often overlooked. By managing discreet ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

After getting a metastatic breast cancer diagnosis, you may experience anxiety and depression. Here are some ways to manage ...

Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...

To further refine risk stratification, other mental health conditions or diagnostic tools should be considered, according to ...